According to a report in Live Mint which quoted data from VCCEdge, outbound mergers and acquisitions in the healthcare sector in India were worth $1.5 billion in 2015 as against $251 million in 2014.
|Lupin, India||Gavis Pharmaceuticals, U.S.||$880 million|
|Cipla, India||InvaGen and Exelan, U.S.||$550 million|
|Strides Arcolab, India||Aspen Pharmacare, Australia||$287 million|
Inbound deals also more than doubled to $999 million in 2015 from $430 million in 2014.
|Mylan, U.S.||Famy-Care, India||$800 million|
|Recipharm AB, Sweden||Nitin Life Sciences, India||$100 million|
|IHH Healthcare Bhd, Malaysia||Ravindranath GE Medical, India||$200 million|
|IHH Healthcare Bhd, Malaysia||Continental Hospitals, India||$45.4 million|
|Temasek Holdings, Singapore||Medanta, India (18% stake)||undisclosed|
|Bionpharma, U.S.||Banner Life Sciences, India (25 products that generate $70 million annually)||undisclosed|